Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Trial of NPC-15 - Study of the Efficacy and Safety for Sleep Disorders of Children With Neurodevelopmental Disorders -

NCT02757079 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.

NCT NCT02757079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02757079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Trial of NPC-15 - Study of the Efficacy and Safety for Sleep Disorders of Children With Neurodevelopmental Disorders -
Lead sponsor
Nobelpharma
Phase
Phase 3
Overall status
Completed
Start date
June 21, 2016
Completion date
July 6, 2018
Enrollment
99 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neurodevelopmental disorder, sleep disorders